Cargando...
A Bayesian approach for unplanned sample sizes in phase II cancer clinical trials
BACKGROUND: Phase II cancer clinical trials commonly employ two-stage designs that incorporate a single interim analysis for lack of efficacy and are designed to achieve specified frequentist properties. The requirement to examine the outcome at a prespecified sample size (SS) can be problematic, be...
Guardado en:
| Publicado en: | Clin Trials |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2012
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4283461/ https://ncbi.nlm.nih.gov/pubmed/22523304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774512443429 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|